as dictated by the data sampling frequency of the stored ECG recording. To study possible effects of heart rate, we performed additional, secondary, analyses in which we normalized that representation for the individual beat-to-beat variation (the RR-interval). To demonstrate that this approach also captures the classical ECG traits, we used previously described genetic variants in aggregate and isolation to visualize their morphological effect on the ECG k-"d . By plotting jgg association signals of each datapoint as -log"g P-values along the time axis of one beat ( Fig. 2 and Supplementary Data 2) , we found that the polygenic risk score of PR-interval associated with a shift of the P-wave; the polygenetic risk score of QRS-duration associated with Q and S-wave durations; the polygenic risk score of "c-lead-sum area matched the area under the curve of the QRS complex; and the polygenetic risk score of QT-time associated with T-wave prolongation. Interestingly, when individual variants of these risk scores were plotted, a plethora of different ECG morphologies was observed, suggesting they are not bound by classic ECG patterns and k indicate differences in underlying biology (Fig. Ra-b, Supplementary Data R) . By examining the genetic heritability along the time-axis of one heartbeat, we observed that electrically active (non-isoelectric) ECG points were more heritable and that our primary ECG phenotype (unadjusted for RR-interval) showed greater heritability (see Fig. Rc) .
k indicate differences in underlying biology ( Fig. Ra-b, Supplementary Data R) . By examining the genetic heritability along the time-axis of one heartbeat, we observed that electrically active (non-isoelectric) ECG points were more heritable and that our primary ECG phenotype (unadjusted for RR-interval) showed greater heritability (see Fig. Rc) .
Next, we performed genome wide association studies (GWAS) on the amplitude of each of the jgg temporal data points of the ECG generating jgg association values per genetic variant (Online Methods). In total k"k independent (r c <g.gg") genetic variants were identified in dd" cMB regions at the traditional genome wide significance threshold (P<jx"g -p ) or cgd independent variants in "ii cMB regions at the stringent bonferroni corrected significance level (P<i.cjx"g -"g ). These k"k independent were assigned to jig candidate genes ( Fig. 5a ., Supplementary Table 2-5). Of all dd" ECG associated regions, "ce were shared ("MB region-based) with loci found in prior GWASes of classical ECG traits; ik regions were shared with the atrial fibrillation phenotype (Supplementary Table 2 and S). We identified "ef genetic association signals that had not been reported before k,j,"k,"j,i-"d . The impact of all genome wide significant genetic variants on ECGmorphology is plotted in Supplementary Data 5, and all genetic variants studied can be viewed online in our ECG-browser (http://www.ecgenetics.org). The three strongest observed association signals were for rse"dcdce (P=kx"g -"kg ) near TBX8, rsipg"fje (P=dx"g -"dd ) in SCN;<A and rscgekcdp (P=cx"g -"cf ) in KCNQ;.
To group genetic variants with similar main effects on the ECG we performed unbiased clustering of the normalized ECG morphology association profiles. This analysis suggested j j subsets of genetic effects on the ECG (Fig. 5b) . Four clusters A, B, D and E contained variants that associated primarily with differences in Q-wave, P-wave, R-S Wave and Twave morphology, respectively (Fig. 5c) . The j th cluster (cluster C) contained a diversity of ECG morphologies, but all variants appear to influence a component of heart rate. Although genetic variants grouped into a cluster sharing morphological features, many expressed unique features within each cluster, pointing towards differences in underlying biology.
To further explore potential biological mechanisms of the ECG-associated genetic loci, we used DEPICT "i and identified ","id enriched biological gene-sets. Among the most significant gene-sets were "heart development", "decreased cardiac muscle contractility", and "embryonic growth retardation". The most significant tissues identified were "heart" , "heart ventricles" and "heart atria" (Supplementary Table T-U). Next, we considered the j distinct subsets identified by unbiased clustering analyses and explored whether these subsets showed differential enrichment for any of the ","id gene-sets (Online Methods).
We found cluster A, related to the Q-wave, to be specifically enriched for c"d pathways related to structural abnormalities of the heart (Fig. 5d) such as "cardiac chamber development" and "dilated cardiomyopathy" (DCM). DCM is a severe clinical heart condition causing substantial morbidity and mortality "e . The genetic variants of this cluster were indeed in close proximity to well known cardiomyopathy genes (e.g. TTN, CAMKAD, OBSL;, BAG8 and HSPBG/CLCNKA) "p-cg .
To exploit the potential for obtaining new clinical insights of this resource, we focussed on a particular point of the Q-wave cluster that showed strong overlap with DCM risk. We i found that rsccdkfic in BAG8 was among the most significant novel loci (P<jx"g -jk ) and was specific for the Q-R upslope at -"pms from the R wave (Fig. S, http://www.ecgenetics.org). This variant was previously identified in a GWAS of DCM "p-cg .
Another newly identified ECG locus was rs"eidigk near HSPBG/CLCNKA (P<jx"g -cg ), also previously identified by a DCM GWAS and exhibiting the same ECG pattern (Fig. S) .
Importantly, associations with this particular ECG morphologic feature persisted in individuals not diagnosed with DCM or other cardiac conditions (Supplementary table   V) . We hypothesized that this Q-R upslope feature (-"ps from R wave) represents a biomarker for DCM risk. To further substantiate this hypothesis, we executed a Mendelian randomization analysis. Using up to ke genetic variants, we observed that an increased Q-R slope is associated with increased risk of DCM (Fig. Sc., Supplementary Table 3-4) .
These findings remained consistent in several sensitivity analyses, across the UK Biobank and the independent MAGNet study cohort. Also exclusion of the c previously known DCM variants did not change our findings (Fig. Se.) . In addition to the known BAG8 and CLCNKA loci, we identified d other DCM variants passing the bonferonni significant treshold (P<g.gg"): rsffgfggk (P=d.jx"g -k ) in PRKCA, rskipjgfg (P=k.cx"g -i ) near LSM8 and rsigpdijde (P=".kx"g -k ) in OBSCN of this Q-R slope trait. The PRKCA locus has previously been found for dilated cardiomyopathy via adverse left ventricular modeling c" . LSM8 and neighboring genes have an unclear role in the heart. OBSCN encodes Obscurin, a signaling protein that plays a major role in the formation of new sacromeres during myofibril assembly and is harboring mutations causing DCM cc . In total "d of ke variants were suggestively associated at P<g.gj with DCM, considerably more than expected by chance e (Pbinomial = d.k x "g -e . These analyses support this new hypothesis that the Q-R slope differences are linked to DCM risk. Further functional studies are important to understand the nature of these associations.
Other examples of cardiac diseases in which the ECG is critical for clinical diagnosis include early repolarisation and the Brugada syndrome. The diagnosis of these conditions are based on strict criteria of passing a certain threshold on the ECG. We hypothesized that the biological underpinnings of these disorders do not adhere to a strict binary phenomenon, and that our understanding of these disorders can be enhanced by studying continuous traits as well. A previous GWAS of the Brugada syndome identified d independent genetic variants cd , all of which were also among our "ii identified loci. Two of the d reported Brugada loci were independent signals in the SCNKA locus encoding the main cardiac sodium channel Nav".j. The biology of the SCNKA locus is highly heterogenous as it has been linked to almost all other ECG traits k,j,"k,"j,i-"d . To further dissect the complex genetic architecture of SCNKA, we performed a compehensive conditional analysis of this locus on the ECG (see Supplementary Information). We identified "g independent variants in the SCNKA locus with an effect on one or more of the jgg data-points of the ECG-morphology (at P<jx"g -p ). These variants all coincide with cardiac enhancer marks (more than expected by chance, Phypergeometric="x"g -e ). We found that that these "g independent SCNKA variants have different morphological ECG signatures, possibly pointing towards different biological mechanisms and consequences for the cardiac conduction system (Supplementary Data S, Supplementary Table 2X).
p Cardiovascular safety is a major concern for many drugs on the market and in development. Our data may contribute to early recognition of potential safety concerns.
Drugs (off-) targeting ion channels are well established examples, including Nav".j (SCNKA), which is targeted by different drugs with cardiac safety concerns ck . Another example are Ikr channels (KCNHA) targeted by class Ia anti-arrythmic drugs including quinidine and the class III anti-arrythmic drug sotalol, both known to prolong QT interval cj , a feature also observed in our data (Extended Fig. 2a; http://www.ecgenetics.org), or drugs targeting Cavd." (CACNA;G) known to affect the PRinterval ci , a feature also observed in our data (Extended Fig. 2b for dilated cardiomyopathy. Eur. Heart J. 5T, "gif-"gee (cg"k).
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Methods

UK Biobank individuals
Participants were recruited with an age range of kg-if years of age that registered with a general practitioner of the UK National Health Service (NHS). Between cggi-cg"g, in total jgd,dcj individuals were included. All study participants provided informed consent and the study was approved by the North West Multi-centre Research Ethics Committee.
Detailed methods used by UK Biobank have been described elsewhere. The prevalence and incidence of cardiac conditions and events were captured by data collected at the Assessment Centre in-patient Health Episode Statistics (HES) download on September "g, cg"e.
Genotyping and imputation
The Wellcome Trust Centre for Human Genetics performed quality control before imputation and imputed to HRC v"." panel that was released on March eth cg"p. Quality control of samples and variants, and imputation was performed by the Wellcome Trust
Centre for Human Genetics, as described in more detail elsewhere cp . Individual sample outliers excluded based on heterozygosity and missingness were excluded, as well as those with gender discrepancies between the reported and inferred gender using X-chromosome heterozygosity test.
"j
Genetics and regression analyses
All of the genetic analyses in UK Biobank that are reported in this manuscript were adjusted for age, gender, BMI, height and the first dg principal components (PCAs) to account for population stratification and genotyping array (Affymetrix UK Biobank Axiom® array or Affymetrix UK BiLEVE Axiom array). ECG variables were inverse rank normalized prior to the association analyses Genome wide association analyses in UK Biobank were performed using BOLT-LMM vc.dbetac. BOLT-LMM fits a mixed linear model that accounts for the population structure and cryptic relatedness. cf For this, directly genotyped variants were used that passed quality control, and which were extracted from the imputed dataset to ensure "gg% call rate, and pruned on linkage disequilibrium (first r c < g.gj and a second round of r c <g.gkj) to obtain roughly kggk variants across the genome. The genomic control lambda's, heritability by BOLT-LMM, LD-Score intercepts and the attenuation ratio statistics are listed in Supplementary Table 22 , these suggested no inflation due to non-polygenic signals dg . Regression analyses of genetic risk scores and individual genetic variant associations across the ECG-morphologies were performed with sandwich robust standard errors that were clustered by family to account for relatedness in STATA-MP v"j. Families were inferred from the kinship matrix, clustering all drd degree relatives or higher together (kinship coefficient > g.gkkc).
For the GWAS we focused on the ECG morphology unadjusted for R-R interval as it was more powerfull compared to the R-R adjusted morphology phenotype; higher heritability, "i captured the large majority of previously identified genetic variants of the ECG and was easiest to interpret. We performed jgg GWAS's, one for each time-point. Using an eigenvalue-based measure d" , we estimated that testing the jgg ECG data points resulted in effectively ef.f independent tests and therefore used an alpha of jx"g -p /pg = i.cjx"g -"g to indicate bonferroni corrected genome wide significance.
Normalized association profiles of variants were plotted as heatmaps where red colors indicate the most strongly associated effect at a time point and the blue color the most strongly associated effect in the opposite direction. To vizualize the similarities further on a c-d plot, we used dimensionality reduction by t-sne on these normalized association profiles for all genome-wide variants, and k-means for clustering. This method only provides a global overview of the primary effects among variants.
ECG morphology phenotypes and quality control
Three-lead exercise ECG data was provided by the UK Biobank as bulk in separate xmlfiles. To isolate R-waves, we employed the gQRS algorithm by George Moody, a public method previously found to be superior dc , the construe algorithm was used to further refine the localization of R-waves dd . Individual ECG beats were processed and averaged d , which we refer to as the 'ECG-morphology' phenotype. Further source code of the methods and descriptions are available at https://github.com/niekverw/E-ECG.
Two entities of ECG morphology were constructed: The primary morphology trait was defined as the classical signal averaged electrocardiographic beat d that consisted of an "e averaged "gggms window surrounding the R wave at a resolution of jgghz resulting in jgg averaged data points or ECG traits for each individual. As such, these beats were unadjusted for individual R-R intervals. The secondary 'ECG morphology' trait consisted of R-R intervals made of equal length (jgg data points) so that the resulting averaged ECG beat was adjusted for each individual R-R interval.
Only information of the rest phase was used, as defined by the first "j seconds of ECG assessment. From all ff,jdf d-lead ECGs recorded in fi,jie participants, ee,"fg ECGs contained full disclosure data nessesary to detect R wave. The R-wave is traditionally used as a reference point to detect all other points on the ECG, hence this should be sufficient to identify major changes ECG-beat, while also easy to understand and visualize.
Before signal averaging, ECG beats were quality controlled on the individual level. First, the d-leads were averaged to create a single ECG signal vector. Then, individual beats containing excess noise were removed as described previously dk,dj , this was based on a moving standard deviation using a window-size of d data points under the assumption that ECG signals without noise have a moving standard deviation close to g. Thirdly, individual beats were matched on a template and discarded if they were dissimilar based on a
Pearson correlation function between each beat; beats with mean negative correlations and those that fell outside the standard ".j interquartile range rule were removed. This procedure was repeated until no outlier beats were left to exclude. At least i beats were required at any stage of the averaging process; otherwise the entire electrocardiogram was excluded from the analysis. We explored whether the averaging process was improved "p when accounting for the lag at which the cross-correlation function between each ECG beats shows its maximum, but this did not make a difference; suggesting that the R-wave detection was already sufficient. In total ie,kkg ECGs of ii,ckg individuals passed the individual level quality control. Diagnoses in UK Biobank were extracted using https://github.com/niekverw/ukpheno.
Polygenic scores of ECG-traits and known genetic variants
Polygenic risk scores were created following an additive model for atrial fibrillation, QT-
interval, QRS duration, PR-interval, QRS-voltage traits ("c-lead sum area, cornel area and
Sokolow-Lyon area) and heart rate separately (Supplementary Table 2R), as previously described di . In short, the number of alleles for each individual (g, " or c) was summed after multiplying the alleles with the previously reported effect size of the variant-trait association. Effect sizes estimated in UK Biobank data were avoided to reduce potential overestimation. If multiple effect sizes were available, those estimated in the largest sample size were used (eg, the combined replication and discovery phase). Singlenucleotide polymorphisms were excluded if they were missing in UK Biobank data. In instances where multiple correlated variants in the same locus were reported for the same trait, we used only independent variants that were selected by the slinkage disequilibrium clumping procedure (at r c < g.g") implemented in PLINK version ".f.
cg
Pathway analyses and candidate genes
DEPICT was employed to discovery pathways, tissues and genes underlying gwas-loci of the electrocardiographic morphology phenotype. Please see Pers et al. for a detailed description of the method "i . All independently associated variants (rc>g.ggj) passing a traditional genome wide significance treshold P < j x "g -p were used as input to the DEPICT framwork. DEPICT was run using default settings. Because DEPICT uses "ggg Genomes as a reference panel which does not include certain UK Biobank specific varianst, we also included all variants in LD (r c >g.p) with the input-variants to ensure "gg% coverage of the signal. Pairwise correlations across all significantly enriched pathways (false discovery rate > g.j%) were computed and vizualized using the Gephi software (www.gephi.org) after filtering out edges with correlations lower than g.j.
For the differential pathway analysis, we repeated the DEPICT pathway analysis but excluded variants that were of interest (variants-of-interest). We calculated the reduction in pathway enrichment by substracting the -log"g(P) for enrichment before and after excluding variants-of-interest. A null distribution was created by repeating the DEPICT run "gg times on the same set of variants but each time excluding a matched number of random variants not belonging to the variants-of-interest. If all "gg null runs indicated that the reduction in significance for a given pathway was more using the variants-of-interest than for the null runs (indicating Pdifferential<g.g"), the pathway was considered to be differentially enriched for the variants-of-interest. Particularly, we were interested whether different biological pathways were active at different ECG intervals. To test this, c"
we used the clusters of variants that were identified in the unbiased clustering aproach by t-sne and k-means as 'variants-of-interest' (see Genetics and association testing); which grouped variants by their primary effect on the different ECG wave intervals in an unbiased manner.
Nearest gene or any gene within "gkb of the lead variants were used to annotate candidate causal genes. We also searched for coding variants in LD with the identified variants (r c >g.p) to further prioritize candidate causal genes. An additional line of evidence for candidate causal genes was performed by DEPICT, taking into account gene-gene similarities across loci "i . We specifically did not incorporate annotations from datasets such as Hi-C and eQTL, as we strongly believe these may not be informative for cardiac conduction biology and need targeted experiments on a per locus basis to interpret them de,dp .
Dilated cardiomyopathy
The association between genetic variants and risk of dilated cardiomyopathy (DCM) was tested in case-control GWASes of UK Biobank and MAGNet (Myocardial Applied Genomics Network) and combined via inverse-variance weighted meta-analysis to increase power totalling ",dej cases and ck",dcj controls.
In the UK Biobank cohort individuals with and without DCM were selected to be independent of those taking part in the ECG measurements. ekk DCM cases were identified according to ICD"g and ICDf codes (Ikc.g and kcjk), cdf,ecf control individuals were not cc diagnosed with DCM and had no family history of heart disease. Association testing was performed as described under 'Genetic and association testing', coefficients were re-scaled to log odds.
For the MAGNet study, id" subjects with dilated cardiomyopathy were recruited; patients were included in the study if they were diagnosed with heart failure with reduced ejection fraction (< kg%) in the absence of hypertension, primary valvular disease, or coronary artery disease from the University of Pennsylvania Health System; ",jfi controls were recruited from the same center who had no history of heart disease. All subjects provided written informed consent. Genotyping was performed on the Illumina OmniExpressExome Array and imputed using the "ggg Genomes Project with Minimac. Genotypes between cases and controls were compared using an additive genetic model adjusting for gender and two principal components of race using SNPtest; there was no genomic inflation (".gddj).
Mendelian randomization
Lead variants associated at P < j × "g −p were used as instrumental variables in the MR.
Enrichment of low P values (P < g.gj) among variants was calculated using a binomial distribution. Mendelian randomization analyses included the inverse-variance-weighted fixed-effects, random-effects meta analyses and weighted median. Heterogeneity was assessed through I c index and Cochran's Q. Pleiotropy analyses included the MR-Egger intercept, MR-RAPS and MR-LASSO estimates df . MR pleiotropy residual sum and outlier (MR-PRESSO) kg was used as MR analysis to detect and remove pleiotropic variants. MRcd PRESSO accounts for pleiotropic effects of the genetic variants comparing the observed distance of all the variants to the regression line (residual sum of squares) to the expected distance under the null hypothesis of no horizontal pleiotropy. MR-PRESSO is based on the assumption that at least jg% of the variants are valid instruments.
For the Mendelian randomization of DCM, variant effects on the ECG morphology at -"p ms were estimated using only individuals without a history of cardiac disease. We performed an additional analysis to explore the impact of pleitropic signals by conducting a c-stage
Mendelian randomization using a discovery and replication stage. First we assessed the causal relationsip in UK Biobank and identified pleitropic outliers by MR-PRESSO.
Secondly, we replicated this analysis by repeating the MR in an independent cohort of id" DCM patients from MAGNet. In this second stage, we excluded the variants identified by MR-PRESSO in the first stage, hence correcting for pleiotropic effects in an unbiased manner.
ck
Data availability
Genome-wide summary statistics can be queried and downloaded from www.ecgenetics.org. Further datasets generated and/or analysed during this study are available from the corresponding authors on reasonable request. Figure 4 
